Ulcerative Colitis News

It is World Inflammatory Bowel Disease Day, and the plight of the estimated one in 35 New Zealanders who have Crohns Disease and Ulcerative Colitis is being highlighted.

The FDA has approved a new use for Simponi injection to treat adults with moderate-to-severe ulcerative colitis.

Santarus, Inc. today announced that additional data from two pivotal clinical studies with UCERIS extended release tablets will be featured in two poster presentations at the Digestive Disease Week Meeting being held in Orlando, Fla.

First and Only Subcutaneous Biologic Treatment Approved to Induce and Maintain Clinical Response and Improve Endoscopic Appearance of the Mucosa During Induction Horsham, PA, - Janssen Biotech, Inc.

Simponi injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.

The U.S. Food and Drug Administration has approved Johnson & Johnson's drug Simponi for patients with moderate to severe ulcerative colitis, an inflammatory disease affecting the colon.

In an effort to help patients living with inflammatory bowel disease , Crohn's disease, and ulcerative colitis in central Pennsylvania, Penn State Hershey Inflammatory Bowel Disease Center experts, led by Dr.

The court also denied Actavis' counterclaim and found that the Shire patent was valid.

This month's issue of the Alimentary Pharmacology & Therapeutics reviews the risk of venous thromboembolism in patients with inflammatory bowel disease.

The drugmakers Actavis Inc. and Warner Chilcott PLC say they are holding early discussions about a possible combination of the two companies.

0843: Markets like what BT had to say this morning. Yes, its 'top-line', or sales only beat consensus estimates mildly.

Shire plc , announces that its subsidiary, Shire Development LLC, has prevailed in its litigation against Watson Pharmaceuticals Inc., Watson Laboratories, Inc.- ", now "Actavis") in connection with their Abbreviated New Drug Application for a generic version of Shire's LIALDA delayed release tablets for the induction of remission in adults with ... (more)

Harlan F. Weisman is CEO of Coronado Biosciences Inc., which saw its stock decline 10 percent Wednesday after reporting a net loss that was bigger than expected.

Main Category: Flu / Cold / SARS Also Included In: Pediatrics / Children's Health ; Crohn's / IBD Article Date: 08 May 2013 - 0:00 PDT Influenza immunization rates in children with inflammatory bowel disease are low despite its safety according to a new study by researchers at the Institute for Clinical Evaluative Sciences , Children's Hospital of ... (more)

Influenza immunization rates in children with inflammatory bowel disease are low despite its safety according to a new study by researchers at the Institute for Clinical Evaluative Sciences , Children's Hospital of Eastern Ontario , the Ottawa Hospital Research Institute , and the University of Ottawa.

Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab, reports this month's Alimentary Pharmacology & Therapeutics.

IT'S a pain in the guts that's putting a hole in the nation's pocket and experts want it nipped in the bud.

According to the results of a survey conducted nearly one year after the European approval of Humira for ulcerative colitis, 69 percent of gastroenterologists pointed to Remicade as their most preferred biologic, while 27 percent of respondents indicated Humira.

Santarus has quietly developed into a thriving bio-pharmaceutical juggernaut with current marketed products consistently showing strong growth and a pipeline full of promise.

A BEWSEY family are among the first in the country to trial a new device which has been giving peace of mind to relatives of elderly residents.